HeadInvest LLC’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.42M Sell
93,068
-12,680
-12% -$601K 0.7% 46
2025
Q4
$5.38M Sell
105,748
-7,316
-6% -$374K 1.07% 30
2025
Q3
$6.27M Sell
113,064
-3,925
-3% -$230K 1.3% 22
2025
Q2
$8.07M Buy
116,989
+3,013
+3% +$205K 1.72% 15
2025
Q1
$7.91M Sell
113,976
-2,251
-2% -$186K 1.54% 16
2024
Q4
$10M Sell
116,227
-3,520
-3% -$381K 1.89% 11
2024
Q3
$14.3M Sell
119,747
-4,875
-4% -$650K 2.64% 5
2024
Q2
$17.8M Sell
124,622
-4,110
-3% -$545K 3.5% 3
2024
Q1
$16.5M Sell
128,732
-7,879
-6% -$938K 3.23% 4
2023
Q4
$14.1M Sell
136,611
-2,407
-2% -$238K 2.94% 4
2023
Q3
$12.8M Sell
139,018
-1,220
-0.9% -$107K 2.77% 4
2023
Q2
$12.7M Sell
140,238
-12,384
-8% -$1.01M 2.74% 5
2023
Q1
$12.1M Sell
152,622
-14,554
-9% -$1.03M 2.66% 5
2022
Q4
$11.3M Sell
167,176
-5,446
-3% -$319K 2.53% 6
2022
Q3
$8.6M Sell
172,622
-2,910
-2% -$156K 2.06% 9
2022
Q2
$9.78M Sell
175,532
-2,724
-2% -$151K 2.18% 8
2022
Q1
$9.9M Sell
178,256
-3,334
-2% -$171K 1.89% 11
2021
Q4
$10.2M Sell
181,590
-6,104
-3% -$331K 1.8% 12
2021
Q3
$9.01M Sell
187,694
-1,718
-0.9% -$83.1K 1.71% 14
2021
Q2
$7.93M Sell
189,412
-686
-0.4% -$26.6K 1.51% 19
2021
Q1
$6.41M Sell
190,098
-1,480
-0.8% -$52.7K 1.31% 22
2020
Q4
$6.69M Buy
191,578
+6,640
+4% +$230K 1.42% 21
2020
Q3
$6.42M Sell
184,938
-2,370
-1% -$79K 1.86% 13
2020
Q2
$6.13M Sell
187,308
-2,034
-1% -$64.9K 1.93% 12
2020
Q1
$5.7M Sell
189,342
-1,434
-0.8% -$42.7K 2.13% 9
2019
Q4
$5.52M Buy
190,776
+726
+0.4% +$20.1K 1.59% 20
2019
Q3
$4.91M Sell
190,050
-8,650
-4% -$219K 1.49% 25
2019
Q2
$5.07M Sell
198,700
-2,410
-1% -$59.6K 1.43% 27
2019
Q1
$5.26M Sell
201,110
-206,550
-51% -$5.08M 1.47% 22
2018
Q4
$9.39M Buy
407,660
+197,980
+94% +$4.4M 1.49% 21
2018
Q3
$4.94M Sell
209,680
-40
-0% -$976 1.42% 23
2018
Q2
$4.84M Sell
209,720
-2,630
-1% -$62.5K 1.47% 23
2018
Q1
$5.23M Sell
212,350
-850
-0.4% -$22.3K 1.68% 22
2017
Q4
$5.72M Sell
213,200
-5,070
-2% -$129K 1.76% 21
2017
Q3
$5.43M Sell
218,270
-1,780
-0.8% -$40.2K 1.7% 20
2017
Q2
$4.72M Buy
220,050
+620
+0.3% +$12.5K 1.55% 21
2017
Q1
$3.76M Sell
219,430
-20
-0% -$348 1.26% 27
2016
Q4
$3.94M Sell
219,450
-2,520
-1% -$45.7K 1.46% 25
2016
Q3
$4.5M Sell
221,970
-3,450
-2% -$85.5K 1.6% 23
2016
Q2
$6.06M Sell
225,420
-3,540
-2% -$97.1K 2.29% 11
2016
Q1
$6.2M Sell
228,960
-1,250
-0.5% -$33.5K 2.43% 7
2015
Q4
$6.68M Sell
230,210
-14,082
-6% -$390K 2.71% 3
2015
Q3
$6.63M Sell
244,292
-2,920
-1% -$82.7K 2.66% 4
2015
Q2
$6.77M Sell
247,212
-7,146
-3% -$201K 2.51% 6
2015
Q1
$6.79M Buy
254,358
+2,296
+0.9% +$52.9K 2.44% 6
2014
Q4
$5.33M Sell
252,062
-3,684
-1% -$82.3K 2.13% 15
2014
Q3
$5.78M Buy
255,746
+310
+0.1% +$7.13K 2.31% 12
2014
Q2
$5.9M Buy
255,436
+9,540
+4% +$211K 2.39% 11
2014
Q1
$5.61M Sell
245,896
-9,284
-4% -$198K 2.42% 11
2013
Q4
$4.71M Sell
255,180
-5,850
-2% -$102K 1.99% 20
2013
Q3
$4.42M Sell
261,030
-4,150
-2% -$69.8K 1.93% 22
2013
Q2
$4.11M Buy
+265,180
New +$4.41M 1.81% 26

Other funds holding NVO

HeadInvest LLC's NVO Position: Q1 2026 in Review

HeadInvest LLC reduced its Novo Nordisk (NVO) stake by 12% in Q1 2026, selling an estimated $601K and leaving 93,068 shares worth $3.42M. The position accounts for 0.7% of the portfolio, ranked #46.

HeadInvest LLC first reported a position in NVO in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.8M in Q2 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • HeadInvest LLC held 93,068 shares of Novo Nordisk worth $3.42M as of Q1 2026.
  • HeadInvest LLC sold 12,680 Novo Nordisk shares in Q1 2026, an estimated $601K.
  • Novo Nordisk made up 0.7% of HeadInvest LLC's portfolio in Q1 2026, its #46 holding.
  • HeadInvest LLC first reported a position in Novo Nordisk in Q2 2013 and has held it in 52 quarters since.
  • HeadInvest LLC's Novo Nordisk position peaked at $17.8M in Q2 2024.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on HeadInvest LLC's 13F filing for Q1 2026, filed 15 May 2026.